OCRFA and Dr. Elizabeth Swisher spoke about the exciting progress being made by the Stand Up to Cancer Ovarian Cancer Dream Team! The SU2C Ovarian Cancer Dream Team, funded by … Continued
(October 5, 2016) A new analysis published in the American Journal of Obstetrics and Gynecology determined the impact of gynecologic surgeon volumes on patient outcomes. Reviewing fourteen studies that involved … Continued
(October 5, 2016) A team of researchers, including senior author and former OCRFA grantee Rugang Zhang, PhD, have been studying the relationship between PD-1 and PD-L1, a protein and an … Continued
Research Advocate, Annie Ellis, recently attended the Biennial Ovarian Cancer Research Symposium presented by the Rivkin Center for Ovarian Cancer and the American Association for Cancer Research. Read her report, … Continued
On September 13th, Abcodia Incorporated, the makers of the ROCA Test, released this statement*, following the safety guidance put out by the FDA last week. ROCA Test sales are now suspended … Continued
Meet Researcher Kris Wood, PhD! Q&A with Kris Wood, PhD Duke University 2015 Liz Tilberis Award OCRFA: Tell me about yourself. Kris Wood: I grew up in Georgetown, KY, a … Continued
(August 16, 2016) While primary cytoreductive surgery followed by chemotherapy is the standard of care for newly diagnosed women with advanced ovarian cancer, newly issued practice guidelines suggest that some … Continued
(Aug 1. 2016) Results of a study reported last month in Cancer show that routine referral of women at high risk for ovarian cancer to genetic counseling promotes genetic testing … Continued
(July 28, 2016) A study published recently in JAMA Oncology showed that CA-125 tests and CT scans are routinely used in ovarian cancer surveillance testing, even though evidence has shown … Continued
Dr. Anne Reb at Walter Reed National Military Medical Center is currently looking for participants in her research study for women who have been diagnosed with Stage 3 or 4 … Continued
(July 18, 2016) The first randomized phase III clinical trial to compare irinotecan and cisplatin with paclitaxel plus carboplatin in patients with clear cell carcinoma (CCC) of the ovary found … Continued
(July 6, 2016) Gynecologic Oncology recently published a study that found that, although surgery leads to longer survival rates, many ovarian cancer patients are not undergoing surgery, and some are … Continued
Get email updates about research news, action alerts, and ways to join the fight.
